Astaxanthin and Increased High-Quality Embryo Count

Doses used in studies

mg/day: 12 (median 12, IQR 12–12) — 1 study

Time to effect

Median: 8 weeks · IQR 8 weeks–8 weeks · Range 8 weeks–8 weeks — Reported in 1 of 1 study

1 of 1 paper

Astaxanthin improves assisted reproductive technology outcomes in poor ovarian responders through alleviating oxidative stress, inflammation, and apoptosis: a randomized clinical trial.

2024-10-31
RCT
Journal of ovarian research 17(1)
- Anahid Shafie
- Ashraf Aleyasin
- Mojtaba Saffari
- Mojtaba Saedi
- Sahar Rostami
- Saeede Rezayi
- Seyed Danial Mohammadi
- Fardin Amidi

PubMed: 39482765
DOI: 10.1186/s13048-024-01537-7

12 Insights on

Increased High-Quality Embryo Count

High evidence
Clinical

The AST group showed significant increases in the number of retrieved oocytes (P=0.003), MII oocytes (P=0.004), frozen embryos (P=0.037), and high-quality embryos (P=0.014) compared to the placebo group.

Effect: Beneficial
Effect size: Small
Significant: Yes
Dose: 12 mg/day